J Med Assoc Thai 2007; 90 (12):2597

Views: 1,555 | Downloads: 40 | Responses: 0

PDF XML Respond to this article Print Alert & updates Request permissions Email to a friend


Very High Dose Phenobarbital for Refractory Status Epilepticus
Tiamkao S Mail, Mayurasakorn N , Mayurasakorn N , Suko P , Suko P , Jitpimolmard S , Jitpimolmard S , Arunpongpaisal S , Arunpongpaisal S , Phuttharak W , Phuttharak W , Auevitchayapat N , Auevitchayapat N , Vannaprasaht S , Vannaprasaht S , Tiamkao S , Tiamkao S , Phunikhom K , Phunikhom K , Chaiyakum A , Chaiyakum A , Saengsuwan J , Saengsuwan J

Background:Refractory status epilepticus (RSE), defined as status epilepticus that fails to respond to first, second and third-line therapy. The RSE is associated with high morbidity and mortality. Treatment guidelines of RSE give a spectrum of options, such as, continuous intravenous (i.v.) midazolam (MDL), or continuous i.v. propofol (PRO) as alternatives to phenobarbital (PB) or continuous i.v. pentobarbital (PTB).

Objective: To study the efficacy of very-high-dose phenobarbital (VHDPB) for treatment RSE.

Study design: Retrospective study.

Material and Method: The authors collected and analyzed data from adult patients who were diagnosed with RSE.

Results: The authors present 10 patients with RSE who were treated with VHDPB. All of them were generalized convulsive status epilepticus (GCSE). Ages ranged from 16-86 years old (mean: 43 years). PB dosage ranged 40-140 mg/kg/day (mean: 70 mg/kg/day). The duration of status epilepticus (SE) varied widely, ranged 1-44 days (mean: 7 days). PB level ranged 35.29-218.34 ug/mL (mean 88.1 ug/mL). RSE was controlled by VHDPB 70%, 30% were not controlled.

Conclusion: VHDPB were considered as alternative treatment for RSE.

Keywords: Refractory status epilepticus, Very high dose phenobarbital, Treatment


Download: PDF